Clinical Pharmacokinetics and Pharmacodynamics of Transarterial Chemoembolization and Targeted Therapies in Hepatocellular Carcinoma Anne HulinJeanick StoccoMohamed Bouattour Review Article 15 May 2019 Pages: 983 - 1014
Revisiting the Pharmacology of Unfractionated Heparin Abdallah DerbalahStephen DuffullHesham Al-Sallami Review Article 09 March 2019 Pages: 1015 - 1028
Clinical Pharmacokinetic and Pharmacodynamic Considerations in the (Modern) Treatment of Melanoma Hannah Yejin KimParth J. UpadhyayAlan V. Boddy Review Article 13 March 2019 Pages: 1029 - 1043
Population Pharmacokinetics of Upadacitinib Using the Immediate-Release and Extended-Release Formulations in Healthy Subjects and Subjects with Rheumatoid Arthritis: Analyses of Phase I–III Clinical Trials Ben KlünderRajendar K. MittapalliAhmed A. Othman Original Research Article Open access 03 April 2019 Pages: 1045 - 1058
Population-Pharmacokinetic Modeling of Tildrakizumab (MK-3222), an Anti-Interleukin-23-p19 Monoclonal Antibody, in Healthy Volunteers and Subjects with Psoriasis Petra JauslinPooja KulkarniThomas Kerbusch Original Research Article 26 March 2019 Pages: 1059 - 1068
Unbound Fraction of Clozapine Significantly Decreases with Elevated Plasma Concentrations of the Inflammatory Acute-Phase Protein Alpha-1-Acid Glycoprotein Wai Hong ManIngeborg WiltingErik M. van Maarseveen Original Research Article Open access 21 May 2019 Pages: 1069 - 1075
Differences in Warfarin Pharmacodynamics and Predictors of Response Among Three Racial Populations Minami OharaYasuhiko SuzukiHarumi Takahashi Original Research Article 28 February 2019 Pages: 1077 - 1089
Pharmacokinetics of the BCL-2 Inhibitor Venetoclax in Subjects with Hepatic Impairment Ahmed Hamed SalemNimita DaveRajeev M. Menon Original Research Article 05 April 2019 Pages: 1091 - 1100
